CClinicalTrials.gg
CompletedNCT06650462Updated Feb 27, 2026

Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1

An interventional study of Community-led discussion in COVID-19 and Trust, sponsored by Old Dominion University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by Old Dominion University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2024, registered Oct 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
57
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Read the detailed description

Eligible participants were randomized to intervention or control group. Intervention group participants met virtually with other community member participants in small discussion groups once a week for one hour over the course of 12 weeks. The online discussion groups were led by peer mentor facilitators and supported by a research team member. Discussion topics included current events, COVID-19, and other health related topics. Control group participants did not meet in weekly discussion groups. At approximately the 0 month, 3 month, and 6 month time points, all participants answered online surveys about health related topics. At the 3 month and 6 month time points, all participants were also asked to self-administer a COVID-19 test that investigators provide. Finally, around the fourth month, intervention group participants were invited to an online feedback session with the research team about participants' experiences in the study.

02

Conditions studied

  • COVID-19
  • Trust

Keywords

  • community-led
  • COVID-19
  • trust
  • vaccine hesitancy
  • peer mentor
  • community advisory board
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 57 is below the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Old Dominion University is the lead sponsor of 25 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18 years or older
  • Resident of one of the 9 housing authority agencies
  • Willing to participate in Zoom meetings and complete online assessments at baseline, 3-month, and 6-month timepoints
  • Ability to read, speak, and understand English

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
57 participants (actual)

Study arms

  • No intervention
    Control

    non-intervention control (participants complete surveys only)

  • Experimental
    Intervention

    Participants engage in weekly community-led small group discussions about health-related topics and answer surveys at 0, 3, and 6 months time points

    Behavioral: Community-led discussion

Interventions

  • BehavioralCommunity-led discussion

    Participants engage in weekly community-led small group discussions about health related topics

06

What researchers measure

Primary outcomes

  1. Openness to COVID-19 testing

    The COVID-19 Testing Openness Questionnaire is an 7-item self-report measure designed to assess participants' openness to getting tested for COVID-19. Each item is rated on a 5-point scale, from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging from 7 to 35. Higher scores indicate greater openness to COVID-19 testing.

    Time frame: 0 months, 3 months, 6 months

  2. COVID-19 Testing Efficacy

    The COVID-19 Testing Efficacy Scale is a 6-item self-report measure that will assess participants' perceived self- and response-efficacy related to COVID-19 testing. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 6 and 30. Higher scores indicate greater efficacy.

    Time frame: 0 months, 3 months, 6 months

  3. COVID-19 Trust

    Two items assessing (1) trust in the safety of the COVID-19 vaccine, and (2) trust in the efficacy of the COVID-19 vaccine were used to assess participants' trust relating to COVID-19. Each item is rated on a 5-point Likert scale. Higher scores indicate greater trust.

    Time frame: 0 months, 3 months, 6 months

  4. Qualitative feedback

    Qualitative feedback will be obtained from participants in a group feedback session

    Time frame: 4 months

Secondary outcomes

  1. COVID-19 Vaccine Hesitancy

    Vaccine Hesitancy was assessed by an item that asked, "Overall, how hesitant about the COVID-19 vaccine would you consider yourself to be?." This question was adapted from the Parent Attitudes about Childhood Vaccines (PACV) survey. The item is scored on a 5-point Likert scale, ranging from "1 - not at all hesitant" to "5 = very hesitant." Higher scores indicate greater hesitancy.

    Time frame: 0 months, 3 months, 6 months

07

Study locations

1 site
  • Macon & Joan Brock Virginia Health Institute at Old Dominion University
    Norfolk, Virginia 23507, United States
08

References and documents

Study documents

  • Study protocol · Nov 7, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06650462
Lead sponsor
Old Dominion University
Responsible party
Kelli J. England (Professor, Old Dominion University) — Principal investigator
First posted
Oct 21, 2024
Start date
Jul 2, 2024
Primary completion
Apr 1, 2025
Completion
Apr 1, 2025
Last update
Feb 27, 2026

Study contacts

Kelli J England, PhD
principal investigator · Old Dominion University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion